Primary Infection Cohort
Recruiting
- Conditions
- HIV-1-infection
- Interventions
- Biological: blood sampling
- First Posted Date
- 2017-05-11
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 2800
- Registration Number
- NCT03148964
- Locations
- 🇫🇷
Laurence Meyer, Le Kremlin Bicêtre, France
Cohort of Patients Naive of Antiretroviral Treatment at Enrollment
Completed
- Conditions
- HIV Infection
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 800
- Registration Number
- NCT03137797
- Locations
- 🇫🇷
Meyer, Kremlin-Bicêtre, France
Prevention of HIV in "Île-de-France"
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 3257
- Registration Number
- NCT03113123
- Locations
- 🇫🇷
Hôpital Européen Georges Pompidou, Paris, France
🇫🇷Hôpital Henry Mondor, Creteil, France
🇫🇷Hôpital Avicenne, Bobigny, France
Methylphenidate for Cocaine Dependence
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Registration Number
- NCT03090269
- Locations
- 🇫🇷
Hôpital Paul Brousse, Villejuif, France
PoC-HCV Genedrive Viral Detection Assay Validation Study
Completed
- Conditions
- Hepatitis C
- Interventions
- Device: HCV RNA detection with Genedrive assayDevice: HCV RNA detection with RealTime HCV
- First Posted Date
- 2016-12-14
- Last Posted Date
- 2016-12-14
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 417
- Registration Number
- NCT02992184
National Multicenter Trial Evaluating Two Treatments in Patients with Primary Human Immunodeficiency Virus (HIV-1) Infection
Phase 3
Completed
- Conditions
- HIV-1 Infection
- Interventions
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 101
- Registration Number
- NCT02987530
- Locations
- 🇫🇷
Hopital Bicetre, All the regions of the country (40 centers), France
An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Phase 1
Terminated
- Conditions
- HIV-1-infection
- Interventions
- Biological: GTU-MultiHIV B-clade vaccine + MVA HIV-B HIV vaccineOther: PlaceboBiological: GTU-MultiHIV B-clade vaccine + MVA HIV-B HIV vaccine+ Vedolizumab
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 1
- Registration Number
- NCT02972450
- Locations
- 🇨🇭
CHUV, Lausanne, Switzerland
🇬🇧Chelsea & Westminster Hospital, London, United Kingdom
Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission
Phase 4
- Conditions
- Hepatitis B Chronic InfectionPregnancy
- Interventions
- Device: Rapid tests HBe Ag
- First Posted Date
- 2016-10-19
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 933
- Registration Number
- NCT02937779
- Locations
- 🇰🇭
Kampong Cham Provincial Hospital, Kampong Cham, Cambodia
🇰🇭Calmette Hospital, Phnom Penh, Cambodia
🇰🇭National Mother and Child Health Center, Phnom Penh, Cambodia
Gut-Associated Lymphocyte Trafficking
Not Applicable
Completed
- Conditions
- HIV-1 Infection
- Interventions
- Other: Peripheral blood and intestinal biopsies will be collected
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 80
- Registration Number
- NCT02906137
- Locations
- 🇫🇷
Hôpital Purpan - Service de Médecine Interne, Toulouse, France
🇫🇷Hôpital Purpan - Service des maladies Infectieuses, Toulouse, France
Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity
Completed
- Conditions
- HIV Infection
- First Posted Date
- 2016-09-01
- Last Posted Date
- 2018-09-28
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 22
- Registration Number
- NCT02886416
© Copyright 2025. All Rights Reserved by MedPath